Medicare Enrolled

Dr. Chiwai Chan, D.O.

Pain Medicine · Fountain Valley, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
11160 WARNER AVE, Fountain Valley, CA 92708
7144249300
In practice since 2005 (20 years)
NPI: 1629051529 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Chan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chan? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Chan

Dr. Chiwai Chan is a pain medicine specialist in Fountain Valley, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Chan performed 53,215 Medicare services across 1,966 unique beneficiaries.

Between the years covered by Open Payments, Dr. Chan received a total of $2,031 from 25 pharmaceutical and/or device companies across 130 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pain medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Chan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 2% volume in CA $2,031 industry payments

Medicare Practice Summary

Medicare Utilization ↗
53,215
Medicare services
Top 2% in CA for pain medicine
1,966
Unique beneficiaries
$16
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~2,661 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Contrast dye for imaging, lower concentration 41,160 $0 $5
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
3,809 $107 $233
Methylprednisolone acetate injection, 20 mg
A 20 mg injection of methylprednisolone acetate, a corticosteroid medication. This code specifies the drug and dosage administered.
1,855 $4 $25
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
1,492 $66 $151
Methylprednisolone acetate injection, 80 mg
An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication.
1,087 $9 $45
Injection, methylprednisolone acetate, 40 mg 1,007 $6 $40
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
562 $58 $178
Viscosupplementation injection for joint
An injection of hyaluronic acid or a derivative into a joint to provide lubrication and cushioning.
522 $59 $200
Fluoroscopic guidance for needle placement
Use of real-time X-ray imaging to guide the precise placement of a needle during a medical procedure.
483 $107 $183
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
219 $145 $422
Sacral spine nerve root injection with imaging guidance
An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement.
181 $331 $578
Spinal or brain drug pump maintenance
A healthcare professional performs maintenance on a drug infusion pump implanted in the spinal canal or brain.
151 $100 $254
Trigger point injection, 3 or more muscles
Injection of medication into three or more specific muscle trigger points to relieve pain.
150 $53 $136
Unclassified drug
A medication that does not fit into standard HCPCS or CPT classification categories.
146 $222 $602
Ultrasound guidance for needle placement
Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure.
138 $52 $491
New patient office visit, complex (60-74 min) 75 $174 $441
Spine facet joint injection with imaging guidance, single level
An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement.
43 $229 $416
Facet joint injection, second level, with imaging guidance
An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated.
43 $120 $204
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
34 $76 $158
Spinal nerve root injection with imaging guidance
An injection of anesthetic or steroid medication into a single nerve root in the upper or middle spine. The procedure uses imaging guidance to ensure accurate placement.
33 $354 $629
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
25 $99 $356
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$2,031
Total received (2018-2024)
Avg $508/year across 4 years
Top 44% in CA for pain medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
25
Companies
130
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,031 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$112
2020
$55
2019
$472
2018
$1,392

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
SCILEX PHARMACEUTICALS INC.
$37
ABBVIE INC.
$30
Valinor Pharma, LLC
$29
Boston Scientific Corporation
$16
Top 3 companies account for 86.1% of 2024 payments
All-time payments by company (2018-2024) ›
Daiichi Sankyo Inc.
$452
PFIZER INC.
$211
Abbott Laboratories
$208
Boston Scientific Corporation
$185
Novartis Pharmaceuticals Corporation
$146
Collegium Pharmaceutical, Inc.
$128
Amgen Inc.
$99
Medtronic USA, Inc.
$82
Nevro Corp.
$65
Jazz Pharmaceuticals Inc.
$59
Indivior Inc.
$40
Scilex Pharmaceuticals Inc.
$40
TerSera Therapeutics LLC
$37
SCILEX PHARMACEUTICALS INC.
$37
ABBVIE INC.
$30
Purdue Pharma L.P.
$29
Valinor Pharma, LLC
$29
Bioventus LLC
$28
Sentynl Therapeutics, Inc.
$26
AstraZeneca Pharmaceuticals LP
$23
FIDIA PHARMA USA INC.
$20
Allergan Inc.
$16
ASSERTIO THERAPEUTICS, Inc.
$15
Horizon Pharma plc
$13
Shionogi Inc
$12
Top 3 companies account for 42.9% of all-time payments
Associated products mentioned in payments ›
AIMOVIG · Aimovig · BOTOX · GELSYN 3 · Gralise · HYALGAN · INTELLIS · LYRICA · Levorphanol · Levorphanol Tartrate · MOVANTIK · Morphabond ER · PENNSAID · PRIALT · Prialt · Proclaim Family of SCS IPGs · SCS IPGs · SPECTRA WAVEWRITER · SUBLOCADE · SYMPROIC · Senza Spinal Cord Stimulation System · Supartz · Symproic · VECTRIS · WaveWriter Alpha Prime 16 · XTAMPZA · XTAMPZAER · Xtampza ER · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a pain medicine specialist in Fountain Valley?
Compare pain medicines in the Fountain Valley area by procedure volume, costs, and industry payment transparency.
Browse pain medicines nearby

Geographic Context

Pain medicines within 10 mi
23
Per 100K population
0.7
County median income
$113,702
Nearest hospital
UCI HEALTH - FOUNTAIN VALLEY
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Chan is a mixed practice specialist, with above-average Medicare volume (top 2% in CA), with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Chan experienced with contrast dye for imaging, lower concentration?
Based on Medicare claims data, Dr. Chan performed 41,160 contrast dye for imaging, lower concentration services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Chan receive payments from pharmaceutical companies?
Yes. Dr. Chan received a total of $2,031 from 25 companies across 130 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Chan's costs compare to other pain medicines in Fountain Valley?
Dr. Chan's average Medicare payment per service is $16. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Chan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →